Comment & Response |

Treatment of Nonmelanoma Skin Cancer

Sherrif F. Ibrahim, MD, PhD1
[+] Author Affiliations
1Division of Dermatologic Surgery, University of Rochester Medical Center, Rochester, New York
JAMA Intern Med. 2013;173(22):2095. doi:10.1001/jamainternmed.2013.10414.
Text Size: A A A
Published online


To the Editor This letter is in response to the recent article by Linos et al.1 As a dermatologic surgeon whose practice is limited to the treatment of nonmelanoma skin cancer (NMSC), a question comes up almost daily from care providers of elderly patients: “My mom is 87, do we really need to treat this?” As the authors mention, although most NMSCs are not life threatening, those of us who manage these diseases are witness to the deep destruction and profound impact on quality of life that they can cause if left untreated. Suspected lesions should always be biopsied because more serious diagnoses such as melanoma or Merkel cell carcinoma are real possibilities, and patients, no matter how old, should be made aware of these conditions. The study does an excellent job of solidifying the safety and efficacy of existing treatments for NMSC. With respect to complications, only 15% of patients responded. These “complications” included minor, temporary symptoms such as numbness and itching, and were not evaluated by the treating physician. There is no reference to complications such as bleeding or infection, presumably because the incidence of these events was low as has been demonstrated previously.2


Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





December 9, 2013
Eleni Linos, MD, DrPH; Charles Seth Landefeld, MD; Mary Margaret Chren, MD
1Department of Dermatology, University of California, San Francisco
2Department of Medicine, University of Alabama, Birmingham
JAMA Intern Med. 2013;173(22):2097. doi:10.1001/jamainternmed.2013.10388.
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...